![Susan M. Aloyan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Susan M. Aloyan
Direttore Tecnico/Scientifico/R&S presso Access Closure, Inc.
Profilo
Susan M.
Aloyan is currently the EVP-Regulatory, Clinical & Quality Affairs at Access Closure, Inc. She previously worked as the Director-Regulatory Affairs at Gynecare, Inc. from 2009 to 2013.
Prior to that, she was the Associate Director-Regulatory Affairs at CardioGenesis Corp.
in 1996.
Susan also held the position of Principal at Syntex Corp.
and Vice President-Regulatory Affairs at Conceptus, Inc. She completed her undergraduate degree at Golden Gate University and her graduate degree at the University of Phoenix.
Posizioni attive di Susan M. Aloyan
Società | Posizione | Inizio |
---|---|---|
Access Closure, Inc.
![]() Access Closure, Inc. Medical SpecialtiesHealth Technology Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Susan M. Aloyan
Società | Posizione | Fine |
---|---|---|
CardioGenesis Corp.
![]() CardioGenesis Corp. Medical SpecialtiesHealth Technology Cardiogenesis Corp. designs, develops, and distributes surgical products for the treatment of refractory angina in patients with chronic cardiac ischemia caused by coronary artery disease. The company was founded by Randy J. Kesten in April 1989 and is headquartered in Irvine, CA. | Corporate Officer/Principal | 01/01/1996 |
Gynecare, Inc. (New Jersey)
![]() Gynecare, Inc. (New Jersey) Medical SpecialtiesHealth Technology Gynecare, Inc. designs medical devices for the treatment of uterine problems. The company was founded on March 8, 1994 and is headquartered in Somerville, NJ. | Consigliere Generale | - |
Syntex Corp. | Corporate Officer/Principal | - |
Conceptus, Inc.
![]() Conceptus, Inc. Medical SpecialtiesHealth Technology Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA. | Consigliere Generale | - |
Formazione di Susan M. Aloyan
Golden Gate University | Undergraduate Degree |
University of Phoenix | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
Access Closure, Inc.
![]() Access Closure, Inc. Medical SpecialtiesHealth Technology Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA. | Health Technology |
Conceptus, Inc.
![]() Conceptus, Inc. Medical SpecialtiesHealth Technology Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA. | Health Technology |
Gynecare, Inc. (New Jersey)
![]() Gynecare, Inc. (New Jersey) Medical SpecialtiesHealth Technology Gynecare, Inc. designs medical devices for the treatment of uterine problems. The company was founded on March 8, 1994 and is headquartered in Somerville, NJ. | Health Technology |
Syntex Corp. | Health Technology |
CardioGenesis Corp.
![]() CardioGenesis Corp. Medical SpecialtiesHealth Technology Cardiogenesis Corp. designs, develops, and distributes surgical products for the treatment of refractory angina in patients with chronic cardiac ischemia caused by coronary artery disease. The company was founded by Randy J. Kesten in April 1989 and is headquartered in Irvine, CA. | Health Technology |
- Borsa valori
- Insiders
- Susan M. Aloyan